0.8680
+0.0104
+(1.21%)
At close: April 15 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
9,848
9,848
6,288
--
--
Operating Expense
73,280
73,280
123,489
137,115
151,398
Operating Income
-63,432
-63,432
-117,201
-137,115
-151,398
Net Non Operating Interest Income Expense
6,808
6,808
9,404
3,911
320
Other Income Expense
-29,455
-29,455
-4,876
--
--
Pretax Income
-86,079
-86,079
-112,673
-133,204
-151,078
Net Income Common Stockholders
-86,079
-86,079
-112,673
-133,204
-151,078
Diluted NI Available to Com Stockholders
-86,079
-86,079
-112,673
-133,204
-151,078
Basic EPS
-1.43
--
-1.95
-2.37
-2.76
Diluted EPS
-1.43
--
-1.95
-2.37
-2.76
Basic Average Shares
60,070
--
57,744
56,201.3980
54,753.5990
Diluted Average Shares
60,070
--
57,744
56,201.3980
54,753.5990
Total Operating Income as Reported
-92,887
-92,887
-122,077
-137,115
-151,398
Total Expenses
73,280
73,280
123,489
137,115
151,398
Net Income from Continuing & Discontinued Operation
-86,079
-86,079
-112,673
-133,204
-151,078
Normalized Income
-56,624
-56,624
-107,797
-133,204
-151,078
Interest Income
6,808
6,808
9,404
3,911
320
Net Interest Income
6,808
6,808
9,404
3,911
320
EBIT
-63,432
-63,432
-117,201
-137,115
-151,398
EBITDA
-61,716
-61,716
-115,065
-134,849
-149,421
Reconciled Depreciation
1,716
1,716
2,136
2,266
1,977
Net Income from Continuing Operation Net Minority Interest
-86,079
-86,079
-112,673
-133,204
-151,078
Total Unusual Items Excluding Goodwill
-29,455
-29,455
-4,876
--
--
Total Unusual Items
-29,455
-29,455
-4,876
--
--
Normalized EBITDA
-32,261
-32,261
-110,189
-134,849
-149,421
12/31/2021 - 10/9/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HLVX HilleVax, Inc.
1.6500
-1.79%
EPIX ESSA Pharma Inc.
1.6300
-1.21%
IKNA Ikena Oncology, Inc.
1.1400
-2.56%
SEER Seer, Inc.
2.1000
+0.48%
ASMB Assembly Biosciences, Inc.
9.81
-3.82%
LYEL Lyell Immunopharma, Inc.
0.4588
+3.19%
IPSC Century Therapeutics, Inc.
0.5010
+0.36%
SPRO Spero Therapeutics, Inc.
0.7444
+6.19%
PMVP PMV Pharmaceuticals, Inc.
1.0400
+9.24%
TIL Instil Bio, Inc.
16.48
-1.90%